3Q17 Earnings Release
Belo Horizonte, November 08, 2017 – Alliar – Centro de Imagem Diagnósticos S.A. hereby announces 3Q17 results.
Highlights:
- Net revenue1 growth of 14.0% in Q3, with same store sales of 7%. YTD growth of 18.0%, SSS of 11%;
- Acceleration of the 2017-2018 organic expansion plan, with the opening of 1 new mega store (reaching a total of 6 inaugurations LTM); final investments on RBD‘s 11 hospitals;
- EBITDA growth of 9.1%, reaching R$ 55.6 million in Q3, with adjusted EBITDA totaling R$ 62.4 million (+2.3%). YTD adjusted EBITDA of R$ 171.3 million (+10.3%);
- Net income (after minority interests) growth of 1811%, reaching R$ 10.2 million in Q3, a R$ 9.7 million expansion YoY;
- Operating cash flow of R$ 45.3 million in Q3 (+85.1%), with 73% cash conversion;
- Issuance of R$ 270.0 million in bonds (concluded in October), with R$ 168.5 million due in 3 years at a cost of 116% of the risk-free rate, and R$ 101.5 million due in 5 years, at a cost of 118% of the risk-free rate;
- Net promoter score (NPS) of 74.0%.
(1) Excludes “construction revenue”, accounting entry referring to the investment made at RBD (PPP Bahia).
Click here to access the Earnings Release.
| Conference Call in English | Conference Call in Portuguese |
|---|---|
| November 09, 2017 12:30 p.m. (Local time) 09:30 a.m. (NY time) Phone: +1 (646) 843-6054 Code: Alliar Webcast: clique aqui |
November, 2017 1:30 p.m. (Local time) 10:30 a.m. (NY time) Phone: +55 (11) 2188-0155 Code: Alliar Webcast: clique aqui |
IR Contact
Frederico de Aguiar Oldani
CFO/IRO
Email: ri@alliar.com